Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type

In this paper design and synthesis of a scaffold comprising primaquine (PQ) motif and cinnamic acid derivatives (CADs) bound directly (compounds 3a–k) or via a spacer (compounds 7a–k) are reported. In the first series of compounds, PQ and various CADs were connected by amide bonds and in the second...

Full description

Bibliographic Details
Main Authors: Kristina Pavić, Ivana Perković, Petra Gilja, Filip Kozlina, Katja Ester, Marijeta Kralj, Dominique Schols, Dimitra Hadjipavlou-Litina, Eleni Pontiki, Branka Zorc
Format: Article
Language:English
Published: MDPI AG 2016-11-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/21/12/1629
id doaj-b39b9f8663f7435fa9d701a1fbb91adf
record_format Article
spelling doaj-b39b9f8663f7435fa9d701a1fbb91adf2020-11-24T23:27:32ZengMDPI AGMolecules1420-30492016-11-012112162910.3390/molecules21121629molecules21121629Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide TypeKristina Pavić0Ivana Perković1Petra Gilja2Filip Kozlina3Katja Ester4Marijeta Kralj5Dominique Schols6Dimitra Hadjipavlou-Litina7Eleni Pontiki8Branka Zorc9Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10 000 Zagreb, CroatiaFaculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10 000 Zagreb, CroatiaFaculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10 000 Zagreb, CroatiaFaculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10 000 Zagreb, CroatiaDivision of Molecular Medicine, Rudjer Bošković Institute, Bijenička cesta 54, HR-10 000 Zagreb, CroatiaDivision of Molecular Medicine, Rudjer Bošković Institute, Bijenička cesta 54, HR-10 000 Zagreb, CroatiaRega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, BelgiumFaculty of Health Sciences, School of Pharmacy, Aristotles University of Thessaloniki, Thessaloniki 54 124, GreeceFaculty of Health Sciences, School of Pharmacy, Aristotles University of Thessaloniki, Thessaloniki 54 124, GreeceFaculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10 000 Zagreb, CroatiaIn this paper design and synthesis of a scaffold comprising primaquine (PQ) motif and cinnamic acid derivatives (CADs) bound directly (compounds 3a–k) or via a spacer (compounds 7a–k) are reported. In the first series of compounds, PQ and various CADs were connected by amide bonds and in the second series by acylsemicarbazide functional groups built from the PQ amino group, CONHNH spacer and the carbonyl group originating from the CADs. PQ-CAD amides 3a–k were prepared by a simple one-step condensation reaction of PQ with a series of CAD chlorides (method A) or benzotriazolides 2 (method B). The synthesis of acylsemicarbazides 7a–k included activation of PQ with benzotriazole, preparation of PQ-semicarbazide 6 and its condensation with CAD chlorides 4. All synthesized PQ-CAD conjugates were evaluated for their anticancer, antiviral and antioxidative activities. Almost all compounds from series 3 were selective towards the MCF-7 cell line and active at micromolar concentrations. The o-fluoro derivative 3h showed high activity against HeLa, MCF-7 and in particular against the SW 620 cell line, while acylsemicarbazide 7f with a benzodioxole ring and 7c, 7g and especially 7j with methoxy-, chloro- or trifluoromethyl-substituents in the para position showed high selectivity and high inhibitory activity against MCF-7 cell line at micromolar (7c, 7f, 7g) and nanomolar (7j) levels. Acylsemicarbazide derivatives with trifluoromethyl group(s) 7i, 7j and 7k showed specific activity against human coronavirus (229E) at concentrations which did not alter the normal cell morphology. The same compounds exerted the most potent reducing activity in the DPPH test, together with 7d and 7g, while methoxy (compounds 7c–e), benzodioxole (7f), p-Cl (7g) and m-CF3 (7i) acylsemicarbazides and amide 3f presented the highest LP inhibition (83%–89%). The dimethoxy derivative 7d was the most potent LOX inhibitor (IC50 = 10 μΜ). The performed biological tests gave evidence of acylsemicarbazide functional group as superior binding group in PQ-CAD conjugates.http://www.mdpi.com/1420-3049/21/12/1629primaquinecinnamic acid derivativeconjugatecytostatic activityantiviral activityantioxidative activity
collection DOAJ
language English
format Article
sources DOAJ
author Kristina Pavić
Ivana Perković
Petra Gilja
Filip Kozlina
Katja Ester
Marijeta Kralj
Dominique Schols
Dimitra Hadjipavlou-Litina
Eleni Pontiki
Branka Zorc
spellingShingle Kristina Pavić
Ivana Perković
Petra Gilja
Filip Kozlina
Katja Ester
Marijeta Kralj
Dominique Schols
Dimitra Hadjipavlou-Litina
Eleni Pontiki
Branka Zorc
Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
Molecules
primaquine
cinnamic acid derivative
conjugate
cytostatic activity
antiviral activity
antioxidative activity
author_facet Kristina Pavić
Ivana Perković
Petra Gilja
Filip Kozlina
Katja Ester
Marijeta Kralj
Dominique Schols
Dimitra Hadjipavlou-Litina
Eleni Pontiki
Branka Zorc
author_sort Kristina Pavić
title Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
title_short Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
title_full Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
title_fullStr Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
title_full_unstemmed Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
title_sort design, synthesis and biological evaluation of novel primaquine-cinnamic acid conjugates of the amide and acylsemicarbazide type
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2016-11-01
description In this paper design and synthesis of a scaffold comprising primaquine (PQ) motif and cinnamic acid derivatives (CADs) bound directly (compounds 3a–k) or via a spacer (compounds 7a–k) are reported. In the first series of compounds, PQ and various CADs were connected by amide bonds and in the second series by acylsemicarbazide functional groups built from the PQ amino group, CONHNH spacer and the carbonyl group originating from the CADs. PQ-CAD amides 3a–k were prepared by a simple one-step condensation reaction of PQ with a series of CAD chlorides (method A) or benzotriazolides 2 (method B). The synthesis of acylsemicarbazides 7a–k included activation of PQ with benzotriazole, preparation of PQ-semicarbazide 6 and its condensation with CAD chlorides 4. All synthesized PQ-CAD conjugates were evaluated for their anticancer, antiviral and antioxidative activities. Almost all compounds from series 3 were selective towards the MCF-7 cell line and active at micromolar concentrations. The o-fluoro derivative 3h showed high activity against HeLa, MCF-7 and in particular against the SW 620 cell line, while acylsemicarbazide 7f with a benzodioxole ring and 7c, 7g and especially 7j with methoxy-, chloro- or trifluoromethyl-substituents in the para position showed high selectivity and high inhibitory activity against MCF-7 cell line at micromolar (7c, 7f, 7g) and nanomolar (7j) levels. Acylsemicarbazide derivatives with trifluoromethyl group(s) 7i, 7j and 7k showed specific activity against human coronavirus (229E) at concentrations which did not alter the normal cell morphology. The same compounds exerted the most potent reducing activity in the DPPH test, together with 7d and 7g, while methoxy (compounds 7c–e), benzodioxole (7f), p-Cl (7g) and m-CF3 (7i) acylsemicarbazides and amide 3f presented the highest LP inhibition (83%–89%). The dimethoxy derivative 7d was the most potent LOX inhibitor (IC50 = 10 μΜ). The performed biological tests gave evidence of acylsemicarbazide functional group as superior binding group in PQ-CAD conjugates.
topic primaquine
cinnamic acid derivative
conjugate
cytostatic activity
antiviral activity
antioxidative activity
url http://www.mdpi.com/1420-3049/21/12/1629
work_keys_str_mv AT kristinapavic designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT ivanaperkovic designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT petragilja designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT filipkozlina designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT katjaester designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT marijetakralj designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT dominiqueschols designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT dimitrahadjipavloulitina designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT elenipontiki designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
AT brankazorc designsynthesisandbiologicalevaluationofnovelprimaquinecinnamicacidconjugatesoftheamideandacylsemicarbazidetype
_version_ 1725551447771185152